BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Piñeiro-Dieguez B, Balanzá-Martínez V, García-García P, Soler-López B; CAT Study Group. Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study. J Atten Disord 2016;20:1066-75. [PMID: 24464326 DOI: 10.1177/1087054713518240] [Cited by in Crossref: 57] [Cited by in F6Publishing: 46] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Harmanci H, Çam Çelikel F, Etikan İ. Comorbidity of Adult Attention Deficit and Hyperactivity Disorder in Bipolar and Unipolar Patients. Noro Psikiyatr Ars 2016;53:257-62. [PMID: 28373804 DOI: 10.5152/npa.2015.11328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
2 Takeda T, Tsuji Y, Uwatoko T, Kurita H. Reliability and validity of ADHD diagnostic criteria in the Assessment System for Individuals with ADHD (ASIA): a Japanese semi-structured diagnostic interview. BMC Psychiatry 2015;15:130. [PMID: 26092179 DOI: 10.1186/s12888-015-0525-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
3 Geffen J, Forster K. Treatment of adult ADHD: a clinical perspective. Ther Adv Psychopharmacol 2018;8:25-32. [PMID: 29344341 DOI: 10.1177/2045125317734977] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
4 Anker E, Bendiksen B, Heir T. Comorbid psychiatric disorders in a clinical sample of adults with ADHD, and associations with education, work and social characteristics: a cross-sectional study. BMJ Open 2018;8:e019700. [PMID: 29500213 DOI: 10.1136/bmjopen-2017-019700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
5 Luderer M, Kaplan-wickel N, Richter A, Reinhard I, Kiefer F, Weber T. Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: Underreporting of ADHD symptoms in self-report scales. Drug and Alcohol Dependence 2019;195:52-8. [DOI: 10.1016/j.drugalcdep.2018.11.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
6 Segenreich D, Paez MS, Regalla MA, Fortes D, Faraone SV, Sergeant J, Mattos P. Multilevel analysis of ADHD, anxiety and depression symptoms aggregation in families. Eur Child Adolesc Psychiatry 2015;24:525-36. [PMID: 25156273 DOI: 10.1007/s00787-014-0604-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
7 McDonald AJ, Cook S, Turner NE, Ialomiteanu AR, Mann RE, Bondy SJ, Roerecke M, McCready J, Millstone D, Hamilton HA, Elton-Marshall T, Rehm J, Kurdyak P, Ilie G, Vingilis ER, Wickens CM, van der Maas M, Cusimano MD. Adult attention-deficit hyperactivity disorder symptoms and psychological distress, hazardous drinking, and problem gambling: A population-based study. Psychiatry Res 2021;301:113985. [PMID: 34023674 DOI: 10.1016/j.psychres.2021.113985] [Reference Citation Analysis]
8 Mardomingo Sanz MJ, Sancho Mateo C, Soler López B; en representación del grupo de investigación del estudio SELFIE., Anexo 1. Grupo de estudio SELFIE. [Assessment of comorbidity and social anxiety in adolescents with attention deficit hyperactivity disorder: the SELFIE study]. An Pediatr (Engl Ed) 2019;90:349-61. [PMID: 30463795 DOI: 10.1016/j.anpedi.2018.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Wynchank D, Bijlenga D, Lamers F, Kooij JJS, Bron TI, Beekman ATF, Penninx BWJH. The Association Between Metabolic Syndrome, Obesity-Related Outcomes, and ADHD in Adults With Comorbid Affective Disorders. J Atten Disord 2018;22:460-71. [PMID: 27422611 DOI: 10.1177/1087054716659137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Schiweck C, Arteaga-Henriquez G, Aichholzer M, Edwin Thanarajah S, Vargas-Cáceres S, Matura S, Grimm O, Haavik J, Kittel-Schneider S, Ramos-Quiroga JA, Faraone SV, Reif A. Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev 2021;124:100-23. [PMID: 33515607 DOI: 10.1016/j.neubiorev.2021.01.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Huang Z, Hoffman CA, Chelette BM, Thiebaud N, Fadool DA. Elevated Anxiety and Impaired Attention in Super-Smeller, Kv1.3 Knockout Mice. Front Behav Neurosci 2018;12:49. [PMID: 29615878 DOI: 10.3389/fnbeh.2018.00049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
12 Tsai FJ, Tseng WL, Yang LK, Gau SS. Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes. PLoS One 2019;14:e0211873. [PMID: 30730956 DOI: 10.1371/journal.pone.0211873] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
13 Correll CU, Starling BR, Huss M. Systematic review of transdermal treatment options in attention-deficit/hyperactivity disorder: implications for use in adult patients. CNS Spectr 2021;:1-13. [PMID: 33843531 DOI: 10.1017/S1092852921000341] [Reference Citation Analysis]
14 Childress A, Cutler AJ, Marraffino AH, Bhaskar S, Donnelly G. Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD. J Atten Disord 2021;:10870547211025610. [PMID: 34189995 DOI: 10.1177/10870547211025610] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Cabana-domínguez J, Shivalikanjli A, Fernàndez-castillo N, Cormand B. Genome-wide association meta-analysis of cocaine dependence: Shared genetics with comorbid conditions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2019;94:109667. [DOI: 10.1016/j.pnpbp.2019.109667] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
16 Kwon SJ, Kim Y, Kwak Y. Difficulties faced by university students with self-reported symptoms of attention-deficit hyperactivity disorder: a qualitative study. Child Adolesc Psychiatry Ment Health 2018;12:12. [PMID: 29434656 DOI: 10.1186/s13034-018-0218-3] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Moulin F, Chollet A, Ramos-Quiroga JA, Bouvard M, Melchior M, Galéra C. Prevalence and Psychosocial Correlates of ADHD Symptoms in Young Adulthood: A French Population-Based Study. J Atten Disord 2018;22:167-81. [PMID: 28490216 DOI: 10.1177/1087054717706758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
18 Ishizuka K, Ishiguro T, Nomura N, Inada T. Depressive mood changes are associated with self-perceptions of ADHD characteristics in adults. Psychiatry Res 2021;300:113893. [PMID: 33799195 DOI: 10.1016/j.psychres.2021.113893] [Reference Citation Analysis]
19 Brandt L, Levin FR, Kraigher D. Impulsive Personality Traits Mediate the Relationship Between Attention-Deficit/Hyperactivity Disorder Symptoms and Psychiatric Comorbidity among Patients with Severe Alcohol Use Disorder. J Dual Diagn 2021;:1-14. [PMID: 34313557 DOI: 10.1080/15504263.2021.1944711] [Reference Citation Analysis]
20 Lee KC, Kim E, Kim J, Malcolm B, Kuo GM, Bird A, Feifel D. Development of an innovative adult attention-deficit hyperactivity disorder clinic. Ment Health Clin 2020;10:296-300. [PMID: 33062556 DOI: 10.9740/mhc.2020.09.296] [Reference Citation Analysis]
21 Hotez E, Rosenau KA, Fernandes P, Eagan K, Shea L, Kuo AA. A National Cross-Sectional Study of the Characteristics, Strengths, and Challenges of College Students With Attention Deficit Hyperactivity Disorder. Cureus. [DOI: 10.7759/cureus.21520] [Reference Citation Analysis]
22 Bahn GH, Lee YS, Yoo HK, Kim EJ, Park S, Han DH, Hong M, Kim B, Lee SI, Bhang SY, Lee SY, Hong JP, Joung YS. Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder. Soa Chongsonyon Chongsin Uihak 2020;31:5-25. [PMID: 32612409 DOI: 10.5765/jkacap.190030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
23 Iwanami A, Saito K, Fujiwara M, Okutsu D, Ichikawa H. Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study. BMC Psychiatry 2020;20:485. [PMID: 33008345 DOI: 10.1186/s12888-020-02867-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Newlove-Delgado T, Hamilton W, Ford TJ, Stein K, Ukoumunne OC. Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink. Atten Defic Hyperact Disord 2019;11:255-62. [PMID: 30730035 DOI: 10.1007/s12402-019-00288-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
25 Koyuncu A, Çelebi F, Ertekin E, Kök BE, Tükel R. Clinical Effects of ADHD Subtypes in Patients With Social Anxiety Disorder. J Atten Disord 2019;23:1464-9. [PMID: 26637843 DOI: 10.1177/1087054715617533] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
26 Machado A, Rafaela D, Silva T, Veigas T, Cerejeira J. ADHD Among Offenders: Prevalence and Relationship With Psychopathic Traits. J Atten Disord 2020;24:2021-9. [DOI: 10.1177/1087054717744880] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
27 Bijlenga D, Vroege JA, Stammen AJM, Breuk M, Boonstra AM, van der Rhee K, Kooij JJS. Prevalence of sexual dysfunctions and other sexual disorders in adults with attention-deficit/hyperactivity disorder compared to the general population. ADHD Atten Def Hyp Disord 2018;10:87-96. [DOI: 10.1007/s12402-017-0237-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
28 Adler LA, Faraone SV, Sarocco P, Atkins N, Khachatryan A. Establishing US norms for the Adult ADHD Self-Report Scale (ASRS-v1.1) and characterising symptom burden among adults with self-reported ADHD. Int J Clin Pract 2019;73:e13260. [PMID: 30239073 DOI: 10.1111/ijcp.13260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
29 Nyström A, Petersson K, Janlöv AC. Being Different but Striving to Seem Normal: The Lived Experiences of People Aged 50+ with ADHD. Issues Ment Health Nurs 2020;41:476-85. [PMID: 32267788 DOI: 10.1080/01612840.2019.1695029] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Klassen LJ, Blackwood CM, Reaume CJ, Schaffer S, Burns JG. A survey of adult referrals to specialist attention-deficit/hyperactivity disorder clinics in Canada. Int J Gen Med 2018;11:1-10. [PMID: 29317844 DOI: 10.2147/IJGM.S145269] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
31 Reimherr FW, Marchant BK, Gift TE, Steans TA. ADHD and Anxiety: Clinical Significance and Treatment Implications. Curr Psychiatry Rep 2017;19. [DOI: 10.1007/s11920-017-0859-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 6.4] [Reference Citation Analysis]
32 Koyuncu A, Çelebi F, Ertekin E, Kök BE, Tükel R. Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series. Ther Adv Psychopharmacol 2017;7:241-7. [PMID: 29090087 DOI: 10.1177/2045125317714193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
33 Kedem S, Yust-Katz S, Carter D, Levi Z, Kedem R, Dickstein A, Daher S, Katz LH. Attention deficit hyperactivity disorder and gastrointestinal morbidity in a large cohort of young adults. World J Gastroenterol 2020; 26(42): 6626-6637 [PMID: 33268951 DOI: 10.3748/wjg.v26.i42.6626] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Lane SJ, Reynolds S. Sensory Over-Responsivity as an Added Dimension in ADHD. Front Integr Neurosci 2019;13:40. [PMID: 31555103 DOI: 10.3389/fnint.2019.00040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Fernàndez-Castillo N, Cabana-Domínguez J, Corominas R, Cormand B. Molecular genetics of cocaine use disorders in humans. Mol Psychiatry 2021. [PMID: 34453125 DOI: 10.1038/s41380-021-01256-1] [Reference Citation Analysis]
36 Ómarsdóttir BS, Kjartansdóttir SH, Magnússon P, Ólafsdóttir H, Sigurðsson JF. Adults referred to a national ADHD clinic in Iceland: clinical characteristics and follow-up status. Nord J Psychiatry 2021;:1-9. [PMID: 33840348 DOI: 10.1080/08039488.2021.1904287] [Reference Citation Analysis]
37 Villas-boas CB, Chierrito D, Fernandez-llimos F, Tonin FS, Sanches AC. Pharmacological treatment of attention-deficit hyperactivity disorder comorbid with an anxiety disorder: a systematic review. International Clinical Psychopharmacology 2019;34:57-64. [DOI: 10.1097/yic.0000000000000243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Al‐khudairi R, Perera B, Solomou S, Courtenay K. Adults with intellectual disability and Attention Deficit Hyperactivity Disorder: Clinical characteristics and medication profiles. Br J Learn Disabil 2019;47:145-52. [DOI: 10.1111/bld.12265] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
39 Oliva F, Mangiapane C, Nibbio G, Berchialla P, Colombi N, Vigna-taglianti F. Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Journal of Psychiatric Research 2020. [DOI: 10.1016/j.jpsychires.2020.11.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Pehlivanidis A, Papanikolaou K, Mantas V, Kalantzi E, Korobili K, Xenaki LA, Vassiliou G, Papageorgiou C. Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/and autism spectrum disorder (ASD). BMC Psychiatry 2020;20:423. [PMID: 32847520 DOI: 10.1186/s12888-020-02828-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
41 Yen YC, Gassen NC, Zellner A, Rein T, Landgraf R, Wotjak CT, Anderzhanova E. Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD. Front Behav Neurosci 2015;9:67. [PMID: 25852508 DOI: 10.3389/fnbeh.2015.00067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
42 López-Pinar C, Martínez-Sanchís S, Carbonell-Vayá E, Sánchez-Meca J, Fenollar-Cortés J. Efficacy of Nonpharmacological Treatments on Comorbid Internalizing Symptoms of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. J Atten Disord 2020;24:456-78. [PMID: 31189374 DOI: 10.1177/1087054719855685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Kok FM, Groen Y, Fuermaier ABM, Tucha O. The female side of pharmacotherapy for ADHD-A systematic literature review. PLoS One 2020;15:e0239257. [PMID: 32946507 DOI: 10.1371/journal.pone.0239257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Sternat T, Fotinos K, Fine A, Epstein I, Katzman MA. Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults. Neuropsychiatr Dis Treat 2018;14:2379-87. [PMID: 30271154 DOI: 10.2147/NDT.S170645] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
45 Connolly RD, Speed D, Hesson J. Probabilities of ADD/ADHD and Related Substance Use Among Canadian Adults. J Atten Disord 2017;23:1454-63. [DOI: 10.1177/1087054716647474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
46 Valsecchi P, Nibbio G, Rosa J, Tamussi E, Turrina C, Sacchetti E, Vita A. Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients. J Atten Disord 2021;25:530-9. [PMID: 30569796 DOI: 10.1177/1087054718819824] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
47 Perugi G, Pallucchini A, Rizzato S, De Rossi P, Sani G, Maremmani AG, Pinzone V, Maremmani I. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opin Pharmacother 2019;20:343-55. [PMID: 30513231 DOI: 10.1080/14656566.2018.1551878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
48 Fillauer JP, Bolden J, Jacobson M, Partlow BH, Benavides A, Shultz JN. Examining the effects of frustration on working memory capacity. Appl Cognit Psychol 2019;34:50-63. [DOI: 10.1002/acp.3587] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]